Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter

Molecular Carcinogenesis

Volumn 21, Issue 1, 1998, Pages 2-12

  Bol, David ^a,c   Kiguchi, Kaoru ^a   Beltrán, Linda ^a   Rupp, Tim ^a   Moats, Samantha ^a   Gimenez Conti, Irma ^a   Jorcano, José ^b   Digiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b CIEMAT   (Spain)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Epithelial homeostasis; erbB2; neu; Skin tumorigenesis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROMOTER REGION; SKIN CARCINOGENESIS; TRANSGENIC MOUSE;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HAIR FOLLICLE; HOMEOSTASIS; HYPERPLASIA; KERATINS; MALE; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; NEOPLASM PROTEINS; PAPILLOMA; PROMOTER REGIONS (GENETICS); SKIN NEOPLASMS; STOMACH; THYMUS GLAND; TRANSGENES;

ANIMALIA; BOVINAE; HYPODERRIS; MUS MUSCULUS; RODENTIA;

EID: 0031908120     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199801)21:1<2::AID-MC2>3.0.CO;2-R     Document Type: Article

References (57)

1. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990.
2. Aaronson SA. Growth factors and cancer. Science 254:1146-1153, 1991.
3. Ullrich A, Coussens L, Hayflick JS, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418-425, 1984.
4. Shih C, Shilo B-Z, Goldfarb MP, Dannenberg A, Weinberg RA. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci USA 76:5714-5718, 1979.
5. Shih C, Padhy LH, Murray M, Weinberg RA. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290:261-264, 1981.
6. Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319:226-230, 1986.
7. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86:9193-9197, 1989.
8. Plowman GD, Whitney GS, Neubauer MG, et al. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87: 4905-4909, 1990.
9. Plowman GD, Culouscou J-M, Whitney GS, et al. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90:1746-1750, 1993.
10. Mason S, Gullick WJ. Type 1 growth factor receptors: An overview of recent developments. The Breast 4:11-18, 1995.
11. Lemmon MA, Schlessinger J. Regulation of signal transduction diversity by receptor oligomerization. Trends Biochem Sci 19:459-463, 1994.
12. Pawson T. SH2 and SH3 domains in signal transduction. Adv Cancer Res 64:87-110, 1994.
13. Holmes WE, Sliwkpwski MX, Akita RW, et al. Identification of heregulin, a specific activator of p185erbB2. Science 256:1205-1210, 1992.
14. Ben-Baruch N, Yarden Y. Neu differentiation factors: A family of alternatively spliced neuronal and mesenchymal factors. Proc Soc Exp Biol Med 206:221-227, 1994.
15. Riese DJ 2nd, Bermingham Y, Van Raaij TM, Buckley S, Plowman GD, Stern DF. Betacellulin activates the epidermal growth factor receptor and erbB-4 and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene 12(2):345-353, 1996.
16. Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI. The neu-oncogene: Signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9:2109-2123, 1994.
17. Karunagaran D, Tzahar E, Beerli RR, et al. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer. EMBO J 15:254-264, 1996.
18. Goldman R, Levy R, Peles E, Yarden Y. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinomas cells: A mechanism for receptor transregulation. Biochemistry 29:11024-11028, 1990.
19. Wada T, Qian X, Greene MI. Intermolecular association of the pi 85neu protein and EGF receptor modulates EGF receptor function. Cell 61:1339-1347, 1990.
20. Earp HS, Dawson TL, Li X, Yu H. Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 35:115-132, 1995.
21. Imamoto A, Beltrán LM, DiGiovanni J. Evidence for autocrine/ paracrine growth stimulation by transforming growth factor-α during the process of skin tumor promotion. Mol Carcinog 4:52-60, 1991.
22. Kiguchi K, Beltrán LM, You J, Rho O, DiGiovanni J. Diverse tumor promoters elevate expression of transforming growth fac tor α mRNA and protein in SENCAR mouse epidermis. Mol Carcinog 12:225-235, 1995.
23. Kiguchi K, Beltrán LM, DiGiovanni J. Altered expression of epidermal growth factor receptor ligands during multistage skin carcinogenesis. Abstract. Proceedings of the American Association for Cancer Research 36:149, 1996.
24. Xian W, Kiguchi K, Imamoto A, Rupp T, Zilberstein A, DiGiovanni J. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice. Cell Growth Differ 6:1447-1455, 1995.
25. Rho O, Beltrán LM, Gimenez-Conti IB, DiGiovanni J. Altered expression of the epidermal growth factor receptor and transforming growth factor-α during multistage skin carcinogenesis in SENCAR mice. Mol Carcinog 11:19-28, 1994.
26. Vassar R, Fuchs E. Transgenic mice provide new insights into the role of TGFα during epidermal development and differentiation. Genes Dev 5:714-727, 1991.
27. Dominey AM, Wang X-J, King LE, et al. Targeted over-expression of transforming growth factor α in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous squamous papillomas. Cell Growth Differ 4:1071-1082, 1993.
28. Jhappan C, Takayama H, Dickson RB, Merlino G. Transgenic mice provide genetic evidence that transforming growth factor α promotes skin tumorigenesis via H-Ras-dependent and H-Ras-independent pathways. Cell Growth Differ 5:385-394, 1994.
29. Vassar R, Hutton ME, Fuchs E. Transgenic overexpression of transforming growth factor α bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol Cell Biol 12:4643-4653, 1992.
30. Wang X-J, Greenhalgh DA, Eckhardt JN, Rothnagel JA, Roop DR. Epidermal expression of transforming growth factor-α in transgenic mice: Induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression. Mol Carcinog 10:15-22, 1994.
31. Ha. Abstract. Proceedings of the American Association for Cancer Research 36:149, 1996.
32. Murillas R, Larcher F, Conti CJ, Santos M, Ullrich A, Jorcano JL. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J 14(21):5216-5223, 1995.
33. Xian W, Rosenberg MP, DiGiovanni J. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: Possible role in mouse skin tumor promotion. Oncogene 14:1435-1444, 1997.
34. Yu DH, Hung MC. Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene 6(11):1991-1996, 1991.
35. Sambrook J, Frítsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, Second Edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1994.
36. Hogan B, Beddington R, Costantini F, Lacy E. Manipulating the Mouse Embryo, A Laboratory Manual, Second Edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1994.
37. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215, 1988.
38. 3H]thymidine administered by injection or osmotic pump. Carcinogenesis 11(12):2245-2251, 1990.
39. Bol DK, Kiguchi K, Gimenez-Conti I, Rupp T, DiGiovanni J. Overexpression of insulin-like growth factor-1 induces hyperpla sia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene 14:1725-1734, 1997.
40. Naito M, Naito Y, DiGiovanni J. Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents. Carcinogenesis 8(12): 1807-1815, 1987.
41. Ramírez A, Bravo A, Jorcano JL, Vidai M. Sequences 5′ of the bovíne keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58:53-64, 1994.
42. Aldaz CM, Conti CJ. The premalignant nature of mouse skin papilloma: Histopathologic, cytogenetic, and biochemical evidence. In: Conti CJ, Klein-Szanto AJP, Slaga TJ (eds), Skin Tu- mors: Experimental and Clinical Aspects. Raven Press, NY, 1989, pp. 227-242.
43. MansbridgeJN, Knapp AM. Changes in keratinocyte maturation during wound healing. J Invest Dermatol 89:253-262, 1987.
44. Toftgard R, Yuspa SH, Roop DR. Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 45:5845-5850, 1985.
45. Molloy CJ, Laskin JD. Specific alterations in keratin biosynthesis in mouse epidermis in vivo and in expiant culture following a single exposure to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 47:4674-4680, 1987.
46. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplification of Her-2/neu oncogene. Science 235:177-182, 1987.
47. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/ neu protooncogene in human breast and ovarian cancer. Science 244:707-712, 1989.
48. DiMarco E, Pierce JH, Kingsley CL, Dffiore PP. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene. Mol Cell Biol 10:3247-3252, 1990.
49. Guy CT, Webster MA, Schaller M, Parson TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578-10582, 1992.
50. Muller WJ, Sinn E, Wallace R, Pattengale PK, Leder P. Singlestep induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115, 1988.
51. Guy CT, Cardiff RD, Muller WJ. Activated neu induces rapid tumor progression. J Biol Chem 271(13):7673-7678, 1996.
52. Maguire HC Jr, Jaworsky C, Cohen JA, Hellman M, Weiner DB, Greene MI. Distribution of neu (c-erbB-2) protein in human skin. J Invest Dermatol 89:786-790, 1989.
53. Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI. The neu-oncogene: Signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9:2109-2123, 1994.
54. 125I] epidermal growth factor in rat epidermis and hair follicles: Accumulation of nuclear label. J Invest Dermatol 88(3):259-265, 1987.
55. Nanney LB, Magid M, Stoscheck CM, King LE Jr. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol 83(5)385-393, 1984.
56. Natali PG, Nicotra MR, Bigotti A, et al. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int J Cancer 45:457-461, 1990.
57. Kokai Y, Cohen J, Drebin JA, Greene MI. Stage- and tissue-specific expression of the neu oncogene in rat development. Proc Natl Acad Sci USA 84:8498-8501, 1987.